Jørgen Buus Lassen

Director/Board Member at Effector A/S

90 year

Health Technology

Transportation

Consumer Services

Profile

Jørgen Buus Lassen is the founder of NTG Nordic Transport Group A, which was founded in 1989.
He held the position of Scientific Director from 1989 to 2008.
Dr. Buus Lassen's current jobs include Director positions at Effector A, Evalua A, and membership at Collegium Internationale Neuro-Psychopharmacologicum.
He formerly held Chairman positions at Zealand Pharma A, NsGene A (1999-2008), Gudme Raaschou Health Care (2003-2010), and Director positions at Nicox SA (1989-2009), Pharmexa A, Gudme Raaschou Invest A, Sophion Bioscience A, Egetis Therapeutics AB, Scanbur A, and Spago Nanomedical AB.
Dr. Buus Lassen earned a doctorate degree from the University of Copenhagen.

Jørgen Buus Lassen active positions

Companies	Position	Start
Effector A/S Effector A/S Miscellaneous Commercial ServicesCommercial Services Effector A/S is a Danish company that specializes in creating effective health communication. The private company is based in Copenhagen, Denmark, and has subsidiaries in Norway. The company develop various exciting projects for their clients.	Director/Board Member	2010-08-10
Evalua A/S	Director/Board Member	2011-09-07
Collegium Internationale Neuro-Psychopharmacologicum	Corporate Officer/Principal	2011-09-07

All active positions of Jørgen Buus Lassen

Former positions of Jørgen Buus Lassen

Companies	Position	End
NICOX SA	Director/Board Member	2013-06-20
Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S (GRI) is an investment management firm based in Copenhagen, Denmark. GRI is a wholly-owned subsidiary of Gudme Raaschou Asset Management Holding A/S, which is a wholly-owned subsidiary of Gudme Raaschou Bank A/S, and ultimately of Copenhagen-based Gudme Raaschou Holding A/S. The firm administers and distributes the Gudme Raaschou Health Care unit trust, as well as the Gudme Raaschou unit trust, which is composed of several compartments: Nordic Alpha, European Bonds, High Yield and US High Yield. Both unit trusts are managed by their affiliate, Gudme Raaschou Asset Management.	Director/Board Member	2011-03-27
Gudme Raaschou Health Care	Chairman	2009-12-31
Pharmexa A/S Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration	Director/Board Member	2009-06-15
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.	Chairman	2008-05-31

See the detail of Jørgen Buus Lassen's experience

Training of Jørgen Buus Lassen

University of Copenhagen

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jørgen Buus Lassen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	5
NICOX SA	Health Technology
NTG NORDIC TRANSPORT GROUP A/S	Transportation
ZEALAND PHARMA A/S	Health Technology
EGETIS THERAPEUTICS AB	Health Technology
SPAGO NANOMEDICAL AB	Health Technology

Private companies	9
Pharmexa A/S Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration	Health Technology
Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S (GRI) is an investment management firm based in Copenhagen, Denmark. GRI is a wholly-owned subsidiary of Gudme Raaschou Asset Management Holding A/S, which is a wholly-owned subsidiary of Gudme Raaschou Bank A/S, and ultimately of Copenhagen-based Gudme Raaschou Holding A/S. The firm administers and distributes the Gudme Raaschou Health Care unit trust, as well as the Gudme Raaschou unit trust, which is composed of several compartments: Nordic Alpha, European Bonds, High Yield and US High Yield. Both unit trusts are managed by their affiliate, Gudme Raaschou Asset Management.
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.	Health Technology
Sophion Bioscience A/S Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark.	Health Technology
Collegium Internationale Neuro-Psychopharmacologicum
Effector A/S Effector A/S Miscellaneous Commercial ServicesCommercial Services Effector A/S is a Danish company that specializes in creating effective health communication. The private company is based in Copenhagen, Denmark, and has subsidiaries in Norway. The company develop various exciting projects for their clients.	Commercial Services
Gudme Raaschou Health Care
Scanbur A/S Scanbur A/S Medical SpecialtiesHealth Technology Scanbur A/S engages in the production and supply of housing, cage changing, cleaning, and decontamination equipment for animal research facilities. It also offers bedding and nesting materials, as well as air handling units. The company was founded on December 18, 1975 and is headquartered in Karlslunde, Denmark.	Health Technology
Evalua A/S

See company connections

Stock Market
Insiders
Jørgen Buus Lassen